Brian Jonas

3 clinical trials · Sponsor

Record	Firm	Date
Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure (NCT04905810)	Brian Jonas	2022-02-09
Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia (NCT04964505)	Brian Jonas	2021-07-02
Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome (NCT02553941)	Brian Jonas	2016-05-17

Every clearance here is in the API, with alerts when new ones post.